Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 4528-4533

  Richt, Jürgen A ^a,c   Fürbringer, Thomas ^a   Koch, Andreas ^b   Pfeuffer, Isolde ^a   Herden, Christiane ^a   Bause Niedrig, Ingrid ^a   Garten, Wolfgang ^b  

^a Institut fur Virologie   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FURIN; FURIN INHIBITOR; GLYCOPROTEIN; GLYCOPROTEIN GP94; SUBTILISIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BORNA DISEASE VIRUS; CHEMICAL STRUCTURE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; STRUCTURE ANALYSIS;

EID: 2642647847     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.4528-4533.1998     Document Type: Article

References (24)

1. Cubitt, B., C. Oldstone, and J. C. de la Torre. 1994. Sequence and genome organization of Borna disease virus. J. Virol. 68:1382-1396.
2. de la Torre, J. C. 1994. Molecular biology of Borna disease virus: prototype of a new group of animal viruses. J. Virol. 68:7669-7675.
3. Feldmann, H., E. Kretzschmar, B. Klingeborn, R. Rott, H.-D. Klenk, and W. Garten. 1988. The structure of serotype H10 hemagglutinin of influenza A virus: comparison of an apathogenic avian and a mammalian strain pathogenic for mink. Virology 165:428-437.
4. Gallaher, W. R. 1996. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell 85:477-478.
5. Garten, W., A. Stieneke, E. Shaw, P. Wikstrom, and H.-D. Klenk. 1989. Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones. Virology 172:25-31.
6. Gonzalez-Dunia, D., B. Cubitt, F. A. Grässer, and J. C. de la Torre. 1997. Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry. J. Virol. 71:3208-3218.
7. Haas, B., H. Becht, and R. Rott. 1986. Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna disease virus. J. Gen. Virol. 67:235-241.
8. Hallenberger, S., V. Bosch, H. Angliker, E. Shaw, H.-D. Klenk, and W. Garten. 1992. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360:358-361.
9. Hallenberger, S., M. Moulard, M. Sordel, H.-D. Klenk, and W. Garten. 1997. The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. J. Virol. 71:1036-1045.
10. Herzog, S., and R. Rott. 1980. Replication of Borna disease virus in cell cultures. Med. Microbiol. Immunol. 168:153-158.
11. Klenk, H.-D., and W. Garten. 1994. Activation cleavage of viral spike proteins, p. 241-280. In E. Wimmer (ed.), Cellular receptors for animal viruses, monograph 28. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
12. Klenk, H.-D., and R. Rott. 1988. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34:247-281.
13. Ludwig, H., K. Furuya, L. Bode, N. Klein, R. Dürrwald, and D. S. Lee. 1993. Biology and neurobiology of Borna disease viruses (BDV), defined by antibodies, neutralizability and their pathogenic potential. Arch. Virol. 7 (Suppl.):111-133.
14. Mackett, M., G. L. Smith, and B. Moss. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49:857-864.
15. Munk, K., E. Pritzer, E. Kretzschmar, B. Gutte, W. Garten, and H.-D. Klenk. 1992. Carbohydrate masking of an antigenic epitope of influenza virus hemagglutinin independent of oligosaccharide size. Glycobiology 2:233-240.
16. Nakayama, K., T. Watanabe, T. Nakagawa, W. S. Kim, M. Nagahama, M. Hosaka, K. Hatsuzawa, K. Kondoh-Hashiba, and K. Murakami. 1992. Consensus sequence for precursor processing at mono-arginyl sites. Evidence for the involvement of a Kex2-like endoprotease in precursor cleavages at both dibasic and mono-arginyl sites. J. Biol. Chem. 267:16335-16340.
17. Richt, J. A., S. VandeWoude, M. C. Zink, J. E. Clements, S. Herzog, L. Stitz, R. Rott, and O. Narayan. 1992. Infection with Borna disease virus: molecular and immunobiological characterization of the agent. Clin. Infect. Dis. 14: 1240-1250.
18. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
19. Schneemann, A., P. A. Schneider, R. A. Lamb, and W. I. Lipkin. 1995. The remarkable coding strategy of Borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology 210:1-8.
20. Schneider, P. A., C. G. Hatalski, A. J. Lewis, and W. I. Lipkin. 1997. Biochemical and functional analysis of the Borna disease virus G protein. J. Virol. 71:331-336.
21. Stieneke-Gröber, A., M. Vey, H. Angliker, E. Shaw, G. Thomas, C. Roberts, H.-D. Klenk, and W. Garten. 1992. Influenza virus hemagglutinin with multi-basic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11:2407-2414.
22. Stitz, L., B. Dietzschold, and K. M. Carbone. 1995. Immunopathogenesis of Borna disease. Curr. Top. Microbiol. Immunol. 190:75-92.
23. Vey, M., W. Schäfer, S. Berghöfer, H.-D. Klenk, and W. Garten. 1994. Maturation of the trans-Golgi network protease furin: compartmentalization of zymogen activation, substrate cleavage, and C-terminal truncation. J. Cell Biol. 127:1829-1842.
24. Wehner, T., A. Ruppert, C. Herden, K. Frese, H. Becht, and J. A. Richt. 1997. Detection of a novel Borna disease virus encoded 10 kilodalton protein in infected cells and tissues. J. Gen. Virol. 78:2459-2466.